natgillin/translations-raw huggingface dataset:
- If you get any side effects, talk to your doctor, nurse or pharmacist. 
- Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom, medicinsko sestro ali farmacevtom.
After reconstitution, chemical and physical in-use stability has been demonstrated for 24 hours at 2°C - 8C or for 4 hours at room temperature. 
Kemijska in fizikalna stabilnost pripravljene raztopine je dokazana za 24 ur pri 2 C - 8 C ali za 4 ure pri sobni temperaturi.
One vial contains 10 mg of basiliximab. 
1 viala vsebuje 10 mg baziliksimaba.
Each vial contains 20 mg of basiliximab. 
Vsaka viala vsebuje 20 mg baziliksimaba.
The reconstituted solution is isotonic and may be given as a bolus injection or diluted to a volume of 25 ml or greater with normal saline or dextrose 50 mg/ml (5%) for infusion. 
Pripravljena raztopina je izotonična in se lahko uporablja kot bolusna injekcija ali razredčena do volumna 25 ml ali več s fiziološko raztopino ali z raztopino glukoze za infuzijo 50 mg/ml (5%).
What Simulect looks like and contents of the pack Simulect comes as a white powder in a colourless glass vial containing 20 mg of basiliximab. 
Zdravilo Simulect je na voljo v obliki praška v prozorni stekleni viali, ki vsebuje 20 mg baziliksimaba.
The reconstituted solution is isotonic and may be given as a bolus injection or diluted to a volume of 50 ml or greater with normal saline or dextrose 50 mg/ml (5%) for infusion. 
Pripravljena raztopina je izotonična in se lahko uporablja kot bolusna injekcija ali razredčena do volumna 50 ml ali več s fiziološko raztopino ali z raztopino glukoze za infuzijo 50 mg/ml (5 %).
Simulect 10 mg powder and solvent for solution for injection or infusion 
Simulect 10 mg prašek in vehikel za raztopino za injiciranje ali infundiranje
Simulect 20 mg powder and solvent for solution for injection or infusion 
Simulect 20 mg prašek in vehikel za raztopino za injiciranje ali infundiranje
Simulect 20 mg powder for solution for injection/infusion basiliximab 
Simulect 20 mg prašek za raztopino za injiciranje/infundiranje baziliksimab intravenska uporaba
The total body clearance of basiliximab was reduced by an average 22% when azathioprine was added to a regimen consisting of ciclosporin for microemulsion and corticosteroids. 
Če so kombinaciji ciklosporina v mikroemulziji in kortikosteroidov dodali azatioprin, se je celotni telesni očistek baziliksimaba zmanjšal za povprečno 22 %.
The total body clearance of basiliximab was reduced by an average 51% when mycophenolate mofetil was added to a regimen consisting of ciclosporin for microemulsion and corticosteroids. 
Če so kombinaciji ciklosporina v mikroemulziji in kortikosteroidov dodali mofetilmikofenolat, se je celotni telesni očistek baziliksimaba zmanjšal za povprečno 51 %.
For infusion, the reconstituted solution should be diluted to a volume of 25 ml or greater with normal saline or dextrose 50 mg/ml (5%). 
Za infuzijo je treba pripravljeno raztopino razredčiti do skupnega volumna 25 ml ali več s fiziološko raztopino ali z raztopino glukoze 50 mg/ml (5-odstotne).
Each vial contains 10 mg of basiliximab. 
Vsaka viala vsebuje 10 mg baziliksimaba.
For infusion, the reconstituted solution should be diluted to a volume of 50 ml or greater with normal saline or dextrose 50 mg/ml (5%). 
Za infuzijo je treba pripravljeno raztopino razredčiti do skupnega volumna 50 ml ali več s fiziološko raztopino ali z raztopino glukoze 50 mg/ml (5-odstotne).
If you get any side effects, talk to your doctor, nurse or pharmacist. 
Če opazite katerega koli izmed neželenih učinkov, se posvetujte z zdravnikom, medicinsko sestro ali farmacevtom.
Do not use if foreign particles are present. 
Če raztopina vsebuje tujke, je ne uporabite.
Simulect 10 mg powder for solution for injection/infusion basiliximab 
Simulect 10 mg prašek za raztopino za injiciranje/infundiranje baziliksimab intravenska uporaba
What Simulect looks like and contents of the pack Simulect comes as a white powder in a colourless glass vial containing 10 mg of basiliximab. 
Zdravilo Simulect je na voljo v obliki praška v prozorni stekleni viali, ki vsebuje 10 mg baziliksimaba.
Powder 
AMPULA
Simulect 20 mg powder and solvent for solution for injection or infusion basiliximab 
Simulect 20 mg prašek in vehikel za raztopino za injiciranje ali infundiranje baziliksimab
Simulect 10 mg powder and solvent for solution for injection or infusion basiliximab 
Simulect 10 mg prašek in vehikel za raztopino za injiciranje ali infundiranje baziliksimab
To prepare the solution for infusion or injection, add 5 ml of water for injections from the accompanying ampoule aseptically to the vial containing the Simulect powder. 
Za pripravo infuzijske ali injekcijske raztopine aseptično dodajte iz priložene ampule 5 ml vode za injekcije v vialo s praškom Simulect.
) in this age group. 
Pri mladostnikih (starost
Powder and solvent for solution for injection or infusion 
Prašek in vehikel za raztopino za injiciranje ali infundiranje Bel prašek
Each vial contains 20 mg basiliximab*. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka viala vsebuje 20 mg baziliksimaba*.
It is important to tell your doctor: 
Pomembno je, da zdravniku poveste:
It may harm them, 
Znaki okužbe sečil so:
However, try to take it at the same time each day. 
Vendar pa jo poskušajte vzeti vsak dan ob istem času.
This will help you to remember to take it. 
To vam bo v pomoč, da se jo boste spomnili vzeti.
Then take your next dose at the usual time. 
Nato vzemite naslednji odmerek ob običajnem času.
The signs of low blood sugar may include: 
Znaki nizkega krvnega sladkorja lahko vključujejo:
• You can take the tablet at any time of the day. 
• Tableto lahko vzamete ob katerem koli času dneva.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 22 May 2014 
Datum prve odobritve: 22. maj 2014
These findings were absent after a 13 weeks drug-free recovery period. 
Ta opažanja so izginila po 13-tedenskem obdobju okrevanja brez zdravila.
• Jardiance can also be used with other medicines. 
• Zdravilo Jardiance se lahko uporablja tudi z drugimi zdravili.
• fainting or loss of consciousness 
• omedlevico ali izgubo zavesti
• if you have “type 1 diabetes”. 
• če imate »sladkorno bolezen tipa 1«.
Measure your blood sugar if possible and rest. 
Če lahko, si izmerite krvni sladkor, in počivajte.
Jardiance is not recommended for children and adolescents under 18 years, because it has not been studied in these patients. 
Zdravilo Jardiance se ne priporoča pri otrocih in mladostnikih, starih manj kot 18 let, saj ga pri teh bolnikih niso preučili.
The adverse reactions are listed by absolute frequency. 
Neželeni učinki so navedeni po absolutni pogostnosti.
• if you are 85 years old or older as you should not start taking Jardiance. 
• če ste stari 85 let ali več, saj ne smete začeti jemati zdravila Jardiance.
Diet and exercise can help your body use its blood sugar better. 
Dieta in vadba vašemu telesu pomagata bolje porabiti krvni sladkor.
24 weeks and maintained for 76 weeks. 
Ta učinek so opazili po 24 tednih in se je ohranil 76 tednov.
Therapeutic experience in patients aged 85 years and older is limited. 
Terapevtske izkušnje pri bolnikih, starih 85 let in več, so omejene.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering. 
Ne uporabljajte tega zdravila, če opazite, da je ovojnina poškodovana ali kaže znake odprtja.
Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. 
Zdravljenje je treba prekiniti pri bolnikih, ki so hospitalizirani zaradi večjih kirurških posegov ali resnih akutnih bolezni.
These changes were not considered to be clinically meaningful. 
Opisane spremembe ne veljajo za klinično pomembne.
• if you are 75 years old or older, as increased passing of urine due to the medicine may affect fluid balance in your body and increase your risk of dehydration. 
• če ste stari 75 let ali več, saj lahko večje izločanje urina zaradi zdravila vpliva na tekočinsko ravnovesje v telesu in poveča vaše tveganje za dehidracijo.
Do not change your dose unless your doctor has told you to. 
Odmerka ne spreminjajte, če vam tega ni naročil zdravnik.
SGLT2 inhibitors should be used with caution in these patients. 
Zaviralce SGLT2 je treba pri teh bolnikih uporabljati previdno.
• Your doctor will prescribe the strength that is right for you. 
• Vaš zdravnik vam bo predpisal odmerek, ki je za vas primeren.
If you forget to take Jardiance What to do if you forget to take a tablet depends on how long it is until your next dose. 
Kaj narediti, če pozabite vzeti tableto, je odvisno od tega, koliko časa je do naslednjega odmerka.
• if you have serious kidney problems - your doctor may ask you to take a different medicine. 
• če imate resne težave z ledvicami - zdravnik vam bo morda svetoval uporabo drugega zdravila.
SGLT2 is highly expressed in the kidney, whereas expression in other tissues is absent or very low. 
SGLT2 je v ledvicah močno izražen, medtem ko je izraženost v drugih tkivih odsotna ali zelo majhna.
The relevance of this finding to humans is unclear. 
Pomen teh izsledkov za ljudi ni znan.
As a precautionary measure, it is preferable to avoid the use of Jardiance during pregnancy. 
Kot previdnostni ukrep se je med nosečnostjo bolje izogibati uporabi zdravila Jardiance.
Thereafter, plasma concentrations declined in a biphasic manner with a rapid distribution phase and a relatively slow terminal phase. 
Koncentracije v plazmi so se nato zmanjševale na bifazni način s hitro fazo razporeditve in relativno počasno končno fazo.
Do not use Jardiance if you are pregnant. 
Ne uporabljajte zdravila Jardiance, če ste noseči.
In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised. 
V obeh primerih je mogoče zdravljenje z empagliflozinom nadaljevati, ko se stanje bolnika stabilizira.
Do not stop taking Jardiance without first consulting your doctor. 
Ne prenehajte jemati zdravila Jardiance, ne da bi se prej posvetovali z zdravnikom.
Improvement of surrogate markers of beta cell function including Homeostasis Model Assessment-β (HOMA-β) was noted. 
Opazili so izboljšanje surogatnih markerjev delovanja beta-celic, vključno z oceno modela homeostaze delovanja B-celic (HOMA-β, Homeostasis Model Assessment-β).
• If it is 12 hours or more until your next dose, take Jardiance as soon as you remember. 
• Če je do naslednjega odmerka 12 ur ali več, vzemite zdravilo Jardiance takoj, ko se spomnite.
What you need to know before you take Jardiance 3. 
Kaj morate vedeti, preden boste vzeli zdravilo Jardiance 3.
This type usually starts when you are young and your body does not produce any insulin. 
Ta tip se običajno pojavi v mladih letih in ko telo insulina ne proizvaja več.
• pain in the pelvis, or mid-back pain (when kidneys are infected) 
• bolečina na področju medenice ali sredini hrbta (če so okužene ledvice)
Remember to take all medicines as directed by your doctor to achieve the best results for your health. 
Ne pozabite, da morate jemati vsa zdravila tako, kot vam je naročil zdravnik, da bo njihovo delovanje za vaše zdravje najboljše.
The maximum daily dose is 25 mg (see below and section 4.4). 
Največji dnevni odmerek je 25 mg (glejte spodaj in poglavje 4.4).
If you have symptoms of low blood sugar, eat glucose tablets, a high sugar snack or drink fruit juice. 
Če imate znake nizkega krvnega sladkorja, pojejte tablete z glukozo, prigrizek z veliko sladkorja ali popijte sadni sok.
The tablet is 11.1 mm long and has a width of 5.6 mm. 
Tableta je dolga 11,1 mm in široka 5,6 mm.
Dehydration, seen uncommonly (may affect up to 1 in 100 people) The signs of dehydration are not specific, but may include: 
Dehidracija, pojavi se občasno (pojavi se lahko pri največ 1 od 100 bolnikov) Znaki dehidracije niso specifični, vendar lahko vključujejo:
Systemic exposure of each metabolite was less than 10% of total drug-related material. 
Sistemska izpostavljenost vsakemu od presnovkov je bila manjša kot 10 % skupne izpostavljenosti zdravilu.
(≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), or very rare (<1/10,000), and not known (cannot be estimated from the available data). 
Pogostnosti so opredeljene kot zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥ 1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000) in zelo redki (<1/10.000) ali neznana (ni mogoče oceniti iz razpoložljivih podatkov).
• Jardiance can be used without other medicines in patients who cannot take metformin (another diabetes medicine). 
• Zdravilo Jardiance se lahko uporablja brez drugih zdravil pri bolnikih, ki ne morejo jemati metformina (drugo zdravilo za zdravljenje sladkorne bolezni).
What Jardiance is and what it is used for 2. 
Kaj je zdravilo Jardiance in za kaj ga uporabljamo 2.
The tablets can be taken with or without food, swallowed whole with water. 
Tablete se lahko jemljejo s hrano ali brez nje; pogoltnejo se cele z vodo.
- Prior to initiation of any concomitant medicinal product that may have a negative impact on renal function. 
- Pred uvedbo katerega koli sočasnega zdravila, ki lahko negativno vpliva na delovanje ledvic.
Co-medication with known inducers of UGT enzymes should be avoided due to a potential risk of decreased efficacy. 
Sočasni uporabi z znanimi induktorji encimov UGT se je treba izogniti zaradi možnega tveganja za zmanjšano učinkovitost.
This may occur regardless of blood glucose level. 
Pojavijo se lahko ne glede na raven glukoze v krvi.
Possible signs of losing too much fluid from your body are listed in section 4 ‘Possible side effects'. 
Možni znaki pretirane izgube tekočine iz telesa so našteti v poglavju 4, »Možni neželeni učinki«.
Four studies had treatment durations of 24 weeks; extensions of those and other studies had patients exposed to empagliflozin for up to 102 weeks. 
V štirih študijah je zdravljenje trajalo 24 tednov; v podaljških teh in drugih študij so bili bolniki empagliflozinu izpostavljeni do 102. tedna.
Possible signs are listed in section 4, ‘Possible side effects' under ‘dehydration'. 
Možni znaki so našteti v poglavju 4, »Možni neželeni učinki« pod “dehidracija”.
The safety and efficacy of empagliflozin in children and adolescents has not yet been established. 
Pediatrična populacija Varnost in učinkovitost empagliflozina pri otrocih in mladostnikih še nista bili dokazani.
If you take more Jardiance than you should If you take more Jardiance than you should, talk to a doctor immediately or go to a hospital immediately. 
Če ste vzeli večji odmerek zdravila Jardiance, kot bi smeli Če ste vzeli večji odmerek zdravila Jardiance, kot bi smeli, se takoj posvetujte z zdravnikom ali pojdite takoj v bolnišnico.
If you have type 2 diabetes, your pancreas does not make enough insulin to control the level of glucose in your blood, and your body is unable to use its own insulin effectively. 
Če imate sladkorno bolezen tipa 2, vaša trebušna slinavka ne tvori dovolj insulina za ureditev ravni glukoze v krvi, vaše telo pa lastnega insulina ne more učinkovito uporabiti.
• if you are taking other medicines that lower the amount of sugar in your blood such as insulin or a “sulphonylurea” medicine. 
• če jemljete druga zdravila, ki zmanjšujejo količino krvnega sladkorja, kot so insulin ali »sulfonilsečninska« zdravila.
The European Medicines Agency has deferred the obligation to submit the results of studies with Jardiance in one or more subsets of the paediatric population in type 2 diabetes mellitus (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom Jardiance za eno ali več podskupin pediatrične populacije s sladkorno boleznijo tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
If a dose is missed, it should be taken as soon as the patient remembers. 
Če bolnik odmerek izpusti, ga mora vzeti takoj, ko se spomni.
The observed increase in urine volume was not dose-dependent and is not clinically meaningful. 
Povečanje volumna urina, ki so ga opazili, ni bilo odvisno od odmerka in klinično ni pomembno.
• if you are being sick, have diarrhoea or fever, or if you are not able to eat or drink. 
• če vam je slabo, imate drisko ali povišano telesno temperaturo ali ne morete jesti ali piti.
• Jardiance is used to treat type 2 diabetes in adult patients (aged 18 years and older) that cannot be controlled by diet and exercise alone. 
• Zdravilo Jardiance se uporablja za zdravljenje sladkorne bolezni tipa 2 pri odraslih bolnikih (starih 18 let in več), ki je ne moremo obvladovati samo z dieto in telesno vadbo.
• You can take the tablet with or without food 
• Tableto lahko vzamete s hrano ali brez nje.
Both tumours are common in rats and are unlikely to be relevant to humans. 
Obe vrsti tumorjev sta pri podganah pogosti in ni verjetno, da bi bili za človeka pomembni.
• passing more urine than usual or needing to pass urine more often 
• večje količine seča od običajnih ali potreba po pogostejšem uriniranju
Patients should be advised to take precautions to avoid hypoglycaemia while driving and using machines, in particular when Jardiance is used in combination with a sulphonylurea and/or insulin. 
Bolnikom je treba svetovati, naj s preventivnimi ukrepi preprečijo hipoglikemijo med vožnjo in upravljanjem strojev, zlasti pri uporabi zdravila Jardiance v kombinaciji s sulfonilsečnino in/ali insulinom.
The majority of drug-related radioactivity recovered in faeces was unchanged parent drug and approximately half of drug related radioactivity excreted in urine was unchanged parent drug. 
Večina radioaktivnosti v blatu, povezane z zdravilom je bila nespremenjena izhodna učinkovina in približno polovica radioaktivnosti v urinu, povezane z zdravilom je bila nespremenjena izhodna učinkovina.
What Jardiance is and what it is used for 
Kaj je zdravilo Jardiance in za kaj ga uporabljamo
Insulin and insulin secretagogues, such as sulphonylureas, may increase the risk of hypoglycaemia. 
Insulin in sekretagogi insulina, kot so sulfonilsečnine, lahko povečajo tveganje za hipoglikemijo.
Due to the mechanism of action, the efficacy of empagliflozin is dependent on renal function. 
Zaradi mehanizma delovanja je učinkovitost empagliflozina odvisna od delovanja ledvic.
Empagliflozin is not genotoxic. 
Empagliflozin ni genotoksičen.
Your doctor has prescribed this medicine to help lower your blood sugar. 
Vaš zdravnik vam je to zdravilo predpisal kot pomoč pri zmanjšanju ravni krvnega sladkorja.
Increased urinary glucose excretion was maintained at the end of the 4-week treatment period, averaging approximately 78 g/day. 
Večje izločanje glukoze v urinu se je ohranilo do konca 4-tedenskega obdobja zdravljenja in je bilo povprečno 78 g/dan.
Your doctor may ask you to stop taking Jardiance until you recover to prevent loss of too much body fluid. 
Vaš zdravnik vam bo morda naročil, da zdravilo Jardiance prenehate jemati, dokler ne okrevate, da preprečite izgubo prevelike količine telesnih tekočin.
(97.5% CI) N 
(97,5-odstotni IZ) N
• if you are taking a medicine used to remove water from the body (diuretic). 
• če uporabljate zdravilo, ki iz telesa odvaja tekočino (diuretik).
Monitoring of renal function 
Spremljanje delovanja ledvic
The frequency of reported nocturia was similar for placebo and empagliflozin (<1%). 
Pogostnost, s katero so poročali o nokturiji, je bila podobna za placebo in za empagliflozin (< 1 %).
It is responsible, as the predominant transporter, for the reabsorption of glucose from the glomerular filtrate back into the circulation. 
Kot prevladujoči prenašalec je odgovoren za reabsorpcijo glukoze iz glomerularnega filtrata nazaj v obtok.
• The starting dose of Jardiance is one 10 mg tablet once a day. 
• Začetni odmerek zdravila Jardiance je ena tableta po 10 mg enkrat na dan.
Experience in New York Heart Association (NYHA) class I-II is limited, and there is no experience in clinical studies with empagliflozin in NYHA class III-IV. 
Izkušnje z razredom I-II po funkcijski razvrstitvi Newyorškega združenja za srce (NYHA, New York Heart Association) so omejene, izkušenj iz kliničnih študij z empagliflozinom z razredom III-IV po NYHA pa ni.
Your doctor may decide to temporarily or permanently stop your treatment with Jardiance. 
Zdravnik se lahko odloči za začasno ali dokončno prekinitev zdravljenja z zdravilom Jardiance.
It is important that you continue with your diet and exercise plan as told by your doctor, pharmacist or nurse. 
Pomembno je, da nadaljujete z dieto in vadbo, kot vam je naročil zdravnik, farmacevt ali medicinska sestra.
• shaking, sweating, feeling very anxious or confused, fast heart beat 
• tresenje, znojenje, občutek tesnobe ali zmedenosti, hiter srčni utrip
Empagliflozin is a substrate of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). 
Empagliflozin je substrat P-glikoproteina (P-gp) in proteina odpornosti pri raku dojke (BCRP, breast cancer resistance protein).
Your doctor may prescribe Jardiance together with another diabetes medicine. 
Zdravnik vam lahko predpiše zdravilo Jardiance skupaj z drugim antidiabetičnim zdravilom.
However, animal studies have shown adverse effects on postnatal development (see section 5.3). 
Vendar pa študije na živalih kažejo neželene učinke na razvoj po rojstvu (glejte poglavje 5.3).
The mechanism of action of empagliflozin is independent of beta cell function and insulin pathway and this contributes to a low risk of hypoglycaemia. 
Mehanizem delovanja empagliflozina je neodvisen od delovanja beta celic in poti insulina, kar prispeva k nižjemu tveganju za hipoglikemijo.
In the population pharmacokinetic analysis, AUC was estimated to be 13.5% higher in Asians with a body mass index of 25 kg/m2 compared to non-Asians with a body mass index of 25 kg/m2. 
V populacijski farmakokinetični analizi so ocenili, da je vrednost AUC za 13,5 % večja pri Azijcih z indeksom telesne mase 25 kg/m2 v primerjavi z ne-Azijci z indeksom telesne mase 25 kg/m2.
During the initial 18 weeks the insulin dose was kept stable, but was adjusted to achieve a FPG <110 mg/dl in the following 60 weeks. 
V prvih 18 tednih je bil odmerek insulina stabilen, a prilagojen tako, da je bila v naslednjih 60 tednih dosežena vrednost FPG < 110 mg/dl.
Jardiance contains lactose (milk sugar). 
Zdravilo Jardiance vsebuje laktozo (mlečni sladkor).
Animal studies do not indicate direct or indirect harmful effects with respect to fertility (see section 5.3). 
Študije na živalih ne kažejo neposrednih ali posrednih škodljivih učinkov na plodnost (glejte poglavje 5.3).
Jardiance should not be used during breast-feeding. 
Zdravila Jardiance se med dojenjem ne sme uporabljati.
There are no data from the use of empagliflozin in pregnant women. 
Podatkov o uporabi empagliflozina pri nosečnicah ni.
Hypoglycaemia The frequency of hypoglycaemia depended on the background therapy in the respective studies. 
Hipoglikemija Pogostnost hipoglikemije je bila odvisna od terapije v ozadju v zadevnih študijah.
This results in high levels of glucose in your blood which can lead to medical problems like heart disease, kidney disease, blindness, and poor circulation in your limbs. 
To povzroči visoke ravni glukoze v krvi, ki imajo lahko za posledico zdravstvene težave, kot so bolezni srca, bolezni ledvic, slepota in slab krvni obtok v okončinah.
In the event of an overdose, treatment should be initiated as appropriate to the patient‘s clinical status. 
Pri prevelikem odmerjanju je treba uvesti ustrezno zdravljenje glede na klinično stanje bolnika.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 
Če vam je zdravnik povedal, da ne prenašate nekaterih sladkorjev, se pred začetkom uporabe tega zdravila posvetujte z zdravnikom.
In patients 75 years and older, an increased risk for volume depletion should be taken into account (see sections 4.4 and 4.8). 
Pri bolnikih, starih 75 let in več, je treba upoštevati večje tveganje za zmanjšanje volumna (glejte poglavji 4.4 in 4.8).